Table 1.
The effectiveness of three mass-screening strategies in a test population of 100,000 persons (when FN/Posa = 0.4). The two-step strategy reduced the number of NAATs performed by approximately 95% compared to NAAT only, with an increase in false negatives by only 24 per 100,000 persons. Both NAAT only and two-step performed significantly better than free entry at limiting the number of false negatives.
NAAT only |
Two-stepb |
Free entry |
|||||||
---|---|---|---|---|---|---|---|---|---|
p | NAAT | Pos | FN | NAAT | Pos | FN | NAAT | Pos | FN |
0·1% | 100,000 | 100 | 40 | 549 [548–550] | 76 [68–83] | 64 [57–72] | 0 | 0 | 140 |
0·2% | 100,000 | 200 | 80 | 558 [556–559] | 152 [136–166] | 128 [114–144] | 0 | 0 | 280 |
0·5% | 100,000 | 500 | 200 | 583 [579–587] | 380 [340–415] | 320 [285–360] | 0 | 0 | 700 |
1·0% | 100,000 | 1000 | 400 | 626 [617–634] | 760 [680–830] | 640 [570–720] | 0 | 0 | 1400 |
FN/Pos: ratio of false negatives to positives; p: proportion of NAAT positivity; NAAT: number of nucleic acid amplification test performed; Pos: number of positive results; FN: number of false positives.
FN/Pos is the ratio of infected persons who test negative to all test positives.
Estimated when the probability of CLEIA-positivity given NAAT-positivity is 76% in point estimates (90% credible interval between 68% and 83%).